FibroGen, Inc. (FGEN) Earnings History
Profitable13 years of earnings data (2012–2024) · Positive TTM net income
Loading earnings history...
FibroGen, Inc. (FGEN) Earnings Overview
As of June 25, 2026, FibroGen, Inc. (FGEN) reported trailing twelve-month net income of $216M, reflecting +83.6% year-over-year growth. The company earned $53.33 per diluted share over the past four quarters, with a net profit margin of -160.6%.
Looking at the long-term picture, FGEN's historical earnings data spans multiple years. The company achieved its highest annual net income of -$15M in fiscal 2013.
FibroGen, Inc. maintains positive profitability with a gross margin of 47.5%, operating margin of -507.8%, and net margin of -160.6%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including AKBA (-$21M net income, -2.3% margin), PTCT (-$187M net income, 39.4% margin), FOLD (-$27M net income, -4.3% margin), FGEN has room to improve margins relative to the peer group. Compare FGEN vs AKBA →
FGEN Earnings vs Peers
Earnings metrics vs comparable public companies
FGEN Historical Earnings Data (2012–2024)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$48M | +83.3% | -$150M | $-0.48 | -160.6% | -507.8% |
| 2023 | -$284M | +3.2% | -$323M | $-2.92 | -607.3% | -689.5% |
| 2022 | -$294M | -1.3% | -$301M | $-3.15 | -208.7% | -213.9% |
| 2021 | -$290M | -53.2% | -$289M | $-3.15 | -123.3% | -122.6% |
| 2020 | -$189M | -145.9% | -$192M | $-2.11 | -107.4% | -108.8% |
| 2019 | -$77M | +10.9% | -$89M | $-0.89 | -30.0% | -34.8% |
| 2018 | -$86M | +31.5% | -$87M | $-1.03 | -40.6% | -40.7% |
| 2017 | -$126M | -104.6% | -$123M | $-1.73 | -100.4% | -97.6% |
| 2016 | -$62M | +28.1% | -$54M | $-0.98 | -34.3% | -29.9% |
| 2015 | -$86M | -44.2% | -$78M | $-1.42 | -47.4% | -42.9% |
| 2014 | -$60M | -298.2% | -$50M | $-1.04 | -43.2% | -36.4% |
| 2013 | -$15M | +54.1% | -$8M | $-0.32 | -14.6% | -7.8% |
| 2012 | -$33M | - | -$27M | $-2.47 | -49.4% | -41.3% |
Download Data
Export FGEN earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
FGEN — Frequently Asked Questions
Quick answers to the most common questions about buying FGEN stock.
What is FGEN earnings per share (EPS)?
FGEN trailing twelve-month (TTM) diluted EPS is $53.33, reflecting +83.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2024 is available in the table on this page.
What is FibroGen, Inc.'s net income?
FibroGen, Inc. (FGEN) trailing twelve-month net income is $216M as of 2024. Earnings grew +83.6% year-over-year.
Is FGEN profitable?
Yes, FGEN is profitable with a TTM net income of $216M and a net profit margin of -160.6%.
What is FGEN's earnings growth rate?
FGEN compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2024.
What are FGEN's profit margins?
FibroGen, Inc. net profit margin is -160.6%, operating margin is -507.8%, and gross margin is +47.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is FGEN growing earnings?
Yes, FGEN earnings are accelerating — EPS growth of +83.6% exceeds the 5-year CAGR of N/A. TTM net income reached $216M. Earnings momentum is strengthening.
What was FGEN's best earnings year?
FibroGen, Inc.'s highest annual net income on record is $-15M, achieved in fiscal year 2013. Earnings history on this page spans 2012 to 2024 and includes all annual and quarterly figures.
What were FGEN's earnings last quarter?
FGEN's most recent reported quarter was Q3 2025. Net income was $201M with diluted EPS of $49.61. For a full breakdown of all quarters, see the quarterly earnings table on this page.